Skip to main content

Symmetry Investments LP

Position in MRVI — Maravai Lifesciences Holdings, Inc.

CIK 1691919 ST HELIER, Y9

Position in MRVI

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$1,017,557
+$175,700 QoQ
Shares Held
359,561
+38.8% QoQ
Ownership
0.139%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in MRVI Over Time

Shares Held

Position Value (USD)

Derivatives in MRVI

reported options exposure · as of Dec 31, 2024
CallValue
$81,750
CallShares
15,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Symmetry Investments LP holds $1,322,357 across 2 Biotechnology names. MRVI ranks #1 (77.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MRVI
Maravai Lifesciences Holdings, Inc.
This page
359,561 $1,017,557

All Filings in MRVI

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,017,557 359,561
2025-12-31 $841,857 259,033
2025-09-30 $817,950 285,000
2025-06-30 $556,710 231,000
2025-03-31 $442,000 200,000
2024-12-31 $81,750 15,000
2024-12-31 $354,250 65,000
2024-09-30 $124,650 15,000
2024-09-30 $290,850 35,000
2024-06-30 $823,400 115,000